Skip to Content

RDY 355 (Rivastigmine Tartrate 6 mg)

Pill with imprint RDY 355 is Brown & Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Rivastigmine is used in the treatment of alzheimer's disease; lewy body dementia; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 355

Rivastigmine Tartrate

Imprint:
RDY 355
Strength:
6 mg
Color:
Brown & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC):
55111-0355

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide